MitoCarta Tree of Life Unveils Diverse Mitochondrial Proteins and Drug Targets

Published across nine scientific papers and summarized in a commentary in the journal Cell, researchers have charted mitochondrial protein catalogs across six diverse organisms to decode the evolutionary history and hidden biochemical pathways of the cell’s energy-generating powerhouse.

Mapping Mitochondrial Diversity Across the Tree of Life

Mitochondria generate adenosine triphosphate, or ATP, to fuel cellular biochemical reactions. Scientists trace this organelle back more than two billion years to an ancestral host cell that engulfed a bacterium. While sequencing mitochondrial DNA has long been straightforward, cataloging entire mitochondrial proteomes across diverse eukaryotes lagged due to technical hurdles.

In 2008, researchers released the MitoCarta inventory of mouse and human mitoproteomes, which subsequently helped identify genes linked to metabolic disease and neurodegeneration. Recognizing that these inventories represented only a fraction of mitochondrial DNA genomes, the MitoTOl Consortium was established in 2022. The consortium aimed to build robust workflows to analyze mitochondrial proteomes across a wider range of eukaryotes.

Targeting Pathogens and Parasites

Technology Networks reported that the consortium concentrated its efforts on five human disease-causing parasites alongside the model plant Arabidopsis. Vamsi Mootha, project leader, noted the selection rationale. The team prioritized pathogenic protists because of their public health significance, vast distribution across the tree of life, and striking molecular diversity containing unstudied pathways. These organisms span approximately one billion years of eukaryotic evolution.

Early mass spectrometry techniques often missed low-abundance mitochondrial proteins, while newer sensitivity gains made it difficult to separate true mitochondrial proteins from co-purifying contaminants. The consortium resolved this by combining serial mitochondrial enrichment and purification with data-independent acquisition mass spectrometry, known as DIA-MS. Protein correlation profiling then analyzed the resulting data.

Mootha explained that DIA-MS delivered deeper proteome coverage without requiring additional upfront fractionations, making it central to the workflow. Microscopy validation and literature curation then augmented the generated inventory to build MitoCarta catalogs for each species.

Reconstructing Eukaryotic Evolution

The consortium used its generated data to train a machine learning predictor of subcellular localization, forecasting roughly 200 mitoproteomes across major eukaryotic lineages. This expanded set allowed researchers to reconstruct the evolutionary timeline of when organelles emerged.

Phylogenetic analysis indicated that mitochondrial endosymbiosis occurred relatively late in eukaryogenesis. Furthermore, the data showed that the mitochondria of the last eukaryotic common ancestor, or LECA, were metabolically flexible and capable of generating ATP through both aerobic and anaerobic pathways.

Uncovering Pan-Parasite Drug Targets

Individual papers published by the consortium detailed new methods for studying tick-borne pathogen and plant mitochondria, ancient adaptations in a blindness-causing organism, and a small mitoproteome lacking energy-producing functions. Thousands of experimentally defined and computationally predicted mitochondrial proteins await functional characterization.

Comparative analysis revealed that many mitochondrial proteins found in pathogens are entirely absent in human hosts. Because mitochondria generally remain essential for these pathogenic protists, the researchers identified them as promising pan-parasite drug targets for neglected tropical diseases. The complete findings and associated commentary appear in Cell.

Photo of author

Sophie Lin - Technology Editor

Sophie is a tech innovator and acclaimed tech writer recognized by the Online News Association. She translates the fast-paced world of technology, AI, and digital trends into compelling stories for readers of all backgrounds.

Microsoft Offers Buyouts to 60,000 Employees Amid AI Restructuring